Evie Carchman, MD, FACS
Associate Professor
- Division of Colorectal Surgery
carchman@surgery.wisc.edu
(608) 262-0422
- Administrative Assistant: (608) 263-2521
Clinical Science Center
600 Highland Avenue
Madison, WI 53792-7375
Education
- MD, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA
- General Surgery Residency, University of Pittsburgh Medical Center, Pittsburgh, PA
- Colon and Rectal Surgery Fellowship, Cleveland Clinic, Cleveland, OH
Clinical Specialties
Dr. Evie Carchman is a fellowship-trained colon and rectal surgeon. She has special expertise in the treatment of colon cancer, rectal cancer, inflammatory bowel disease, benign conditions of colon, rectum, and anus, and endoscopic treatment of colonic disease. Dr. Carchman utilizes minimally invasive techniques including laparoscopic and single incision laparoscopic surgery for the treatment of colon and rectal disease.
Dr. Carchman provides a wide range of services including Abdominoperineal Resection, Abscess Drainage, Endorectal Advancement Flap, Fistulotomy, Flap Repair, Hemorrhoid Banding, Hemorrhoidectomy, Ileocolic Resection, Laparoscopic and Open Partial Colectomy, Laparoscopic and Open Rectopexy, Laparoscopic and Open Sigmoid Resection, Laparoscopic and Open Total Colectomy, Lateral Internal Sphincterotomy, Lower Anterior Resection (LAR), Pilonidal Cyst Excision, Sphincter Repair (overlapping sphincteroplasty), Total Proctocolectomy, Transanal Proctosigmoidectomy.
Research Interests
Dr. Carchman’s Research Lab >>
Dr. Carchman’s research interests focus on the pathogenesis and treatment of anal cancer. She has special expertise in the treatment of colon cancer, rectal cancer, inflammatory bowel disease, benign conditions of colon, rectum, and anus, and endoscopic treatment of colonic disease. Dr. Carchman utilizes minimally invasive techniques including laparoscopic and single incision laparoscopic surgery for the treatment of colon and rectal disease.
Recent Publications
Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity.
Kratz JD, Rehman S, Johnson KA, Gillette AA, Sunil A, Favreau PF, Pasch CA, Miller D, Zarling LC, Yeung AH, Clipson L, Anderson SJ, Steimle AK, Sprackling CM, Lemmon KK, Abbott DE, Burkard ME, Bassetti MF, Eickhoff JC, Foley EF, Heise CP, Kimple RJ, Lawson EH, LoConte NK, Lubner SJ, Mulkerin DL, Matkowskyj KA, Sanger CB, Uboha NV, Mcilwain SJ, Ong IM, Carchman EH, Skala MC, Deming DA
Sci Rep 2025 Apr 09; 15(1): 12072
[PubMed ID: 40200028]Laser Hair Removal May Be a Primary Treatment of Pilonidal Disease: A Pilot Study.
Janek KC, Kenfield M, Stafford LC, Stalter L, Carchman E, Leys CM, Nichol P, Brinkman A, Arkin LM, Le HD
J Pediatr Surg 2025 Apr; 60(4): 162182
[PubMed ID: 39893840]National Analysis of More Than 48,000 Veterans With HIV Demonstrates CD4/CD8 Ratio as a Risk Marker for Anal Intraepithelial Lesions and Anal Cancer.
Hewitt AJ, Freeman MJ, Leverson GE, Bailey HH, Carchman EH, Striker R, Sanger CB
Dis Colon Rectum 2025 Apr 01; 68(4): 399-407
[PubMed ID: 39745282]Anal cancer prevention: A field in need of scientific Advancement.
Carchman E, Sanger CB
Virology 2025 Jan; 602: 110323
[PubMed ID: 39622097]Pathophysiology of Anal Cancer.
Lozar T, Carchman E
Surg Oncol Clin N Am 2025 Jan; 34(1): 21-35
[PubMed ID: 39547766]